Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

A drug used for rheumatoid arthritis might regrow hair in alopecia areata patients

Tofacitinib Citrate May Stimulate Hair Regrowth in Alopecia Areata

0
However, drug cessation resulted in disease relapse in 8.5 weeks
For buprenorphine prescribers

Physicians Treating Few Patients With Buprenorphine

0
22 percent of prescribers had monthly census of one to three patients; 9 percent had >75 patients
A non-tumor necrosis factor (TNF)-targeted biologic is more effective than a second anti-TNF drug for treatment of rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug

Non-TNF Biologic Beats Second Anti-TNF in Rheumatoid Arthritis

0
Findings in patients with rheumatoid arthritis with insufficient response to first anti-TNF drug
Gemigliptin combined with metformin is superior to monotherapy with either drug for patients with type 2 diabetes mellitus

Gemigliptin, Metformin Combo Beats Monotherapy in T2DM

0
Greater change in HbA1c from baseline to 24 weeks with combination therapy versus monotherapies
For patients with chronic hepatitis C

Most Patients Prefer Oral Dual Therapy in Chronic Hepatitis C

0
High response rate for dual therapy among cohort of patients with predominant genotype 3
For young adults with acute lymphoblastic leukemia

Adding Rituximab to Chemo Ups Event-Free Survival in ALL

0
Findings in young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia
For postmenopausal women with osteoporosis

ASBMR: Romosozumab Linked to Reduced Fracture Risk

0
Reduced vertebral fracture risk at 12 months among postmenopausal women with osteoporosis
Codeine is unsafe for children and should no longer be given to them

AAP Says Codeine Not Safe for Children, Urges Restrictions

0
Doctors should avoid giving drug to children undergoing tonsillectomy, adenoidectomy
For patients with or without dysglycemia or metabolic syndrome

Evolocumab Safe, Effective for Those With Dysglycemia, MetS

0
Reduction in LDL-C in all subgroups, including those with, without dysglycemia and metabolic syndrome
Semaglutide is noninferior to placebo for patients with type 2 diabetes at high cardiovascular risk

Rate of CVD Mortality, MI, Stroke Down for Patients on Semaglutide

0
Study confirms the noninferiority of semaglutide